MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
Google Scholar
Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–61.
Google Scholar
Tüfekci KU, Meuwissen RLJ, Genç S. The role of MicroRNAs in biological processes. Methods Mol Biol. 2014;1107:15–31.
Google Scholar
Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004.
Google Scholar
Ostrom QT, Adel Fahmideh M, Cote DJ, Muskens IS, Schraw JM, Scheurer ME, et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21(11):1357–75.
Google Scholar
Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035.
Google Scholar
Patel DR, Merrick J. Neurodevelopmental and neurobehavioral disorders. Transl Pediatr. 2020;9:S1–2.
Google Scholar
O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.
Google Scholar
Alarcón CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519(7544):482–5.
Google Scholar
Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004;18(24):3016–27.
Google Scholar
Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, Hannon GJ. Processing of primary microRNAs by the microprocessor complex. Nature. 2004;432(7014):231–5.
Google Scholar
Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436(7051):740–4.
Google Scholar
Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–24.
Google Scholar
Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, et al. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol. 2010;17(1):17–23.
Google Scholar
Ali Syeda Z, Langden SSS, Munkhzul C, Lee M, Song SJ. Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 2020;21(5):1723.
Google Scholar
Zhang J, Zhou W, Liu Y, Liu T, Li C, Wang L. Oncogenic role of microRNA-532-5p in human colorectal cancer via targeting of the 5’UTR of RUNX3. Oncol Lett. 2018;15(5):7215–20.
Google Scholar
Dharap A, Pokrzywa C, Murali S, Pandi G, Vemuganti R. MicroRNA miR-324-3p induces promoter-mediated expression of RelA gene. PLoS One. 2013;8(11):e79467.
Google Scholar
Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA. 2008;105(39):14879–84.
Google Scholar
Jo MH, Shin S, Jung SR, Kim E, Song JJ, Hohng S. Human argonaute 2 has diverse reaction pathways on target RNAs. Mol Cell. 2015;59(1):117–24.
Google Scholar
Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2. Cell. 2007;128(6):1105–18.
Google Scholar
Zeinali T, Mansoori B, Mohammadi A, Baradaran B. Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis. Biomed Pharmacother. 2019;109:195–207.
Google Scholar
Liguoro D, Frigerio R, Ortolano A, Sacconi A, Acunzo M, Romano G, et al. The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors. Cell Death Dis. 2024;15(3):208.
Google Scholar
Shi X, Kaller M, Rokavec M, Kirchner T, Horst D, Hermeking H. Characterization of a p53/miR-34a/CSF1R/STAT3 feedback loop in colorectal cancer. Cell Mol Gastroenterol Hepatol. 2020;10(2):391–418.
Google Scholar
Ong ALC, Ramasamy TS. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018;43:64–80.
Google Scholar
Huan C, Xiaoxu C, Xifang R. Zinc finger protein 521, negatively regulated by MicroRNA-204-5p, promotes proliferation, motility and invasion of gastric cancer cells. Technol Cancer Res Treat. 2019;18:1533033819874783.
Google Scholar
Liu S, Li X, Zhuang S. miR-30c impedes glioblastoma cell proliferation and migration by targeting SOX9. Oncol Res. 2019;27(2):165–71.
Google Scholar
Seipel K, Messerli C, Wiedemann G, Bacher U, Pabst T. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation. Leuk Res. 2020;89:106296.
Google Scholar
Shindo T, Niinuma T, Nishiyama N, Shinkai N, Kitajima H, Kai M, et al. Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer. Oncotarget. 2018;9(36):24457–69.
Google Scholar
Grasso G, Higuchi T, Mac V, Barbier J, Helsmoortel M, Lorenzi C, et al. NF90 modulates processing of a subset of human pri-miRNAs. Nucleic Acids Res. 2020;48(12):6874–88.
Google Scholar
Wang Y, Zou R, Li D, Gao X, Lu X. Exosomal circSTRBP from cancer cells facilitates gastric cancer progression via regulating miR-1294/miR-593-3p/E2F2 axis. J Cell Mol Med. 2024;28(8):e18217.
Google Scholar
Kadkhoda S, Eslami S, Mahmud Hussen B, Ghafouri-Fard S. A review on the importance of miRNA-135 in human diseases. Front Genet. 2022;13:973585.
Google Scholar
Mannironi C, Biundo A, Rajendran S, De Vito F, Saba L, Caioli S, et al. miR-135a regulates synaptic transmission and anxiety-like behavior in amygdala. Mol Neurobiol. 2018;55(4):3301–15.
Google Scholar
Zheng K, Hu F, Zhou Y, Zhang J, Zheng J, Lai C, et al. miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease. Nat Commun. 2021;12(1):1903.
Google Scholar
Zhang X, Lu J, Zhang Q, Luo Q, Liu B. CircRNA RSF1 regulated ox-LDL induced vascular endothelial cells proliferation, apoptosis and inflammation through modulating miR-135b-5p/HDAC1 axis in atherosclerosis. Biol Res. 2021;54(1):11.
Google Scholar
Chen B, Yang W, Zhao H, Liu K, Deng A, Zhang G, et al. Abnormal expression of miR-135b-5p in bone tissue of patients with osteoporosis and its role and mechanism in osteoporosis progression. Exp Ther Med. 2020;19(2):1042–50.
Google Scholar
Xie B, Lu C, Chen C, Zhou J, Deng Z. miR-135a alleviates silica-induced pulmonary fibrosis by targeting NF-κB/inflammatory signaling pathway. Mediators Inflamm. 2020;2020:1231243.
Google Scholar
Ahmad A, Zhang W, Wu M, Tan S, Zhu T. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes. Genes Genomics. 2018;40(3):243–51.
Google Scholar
Mao XW, Xiao JQ, Li ZY, Zheng YC, Zhang N. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway. Exp Mol Med. 2018;50(1):e429.
Google Scholar
Bhinge A, Poschmann J, Namboori SC, Tian X, Jia Hui Loh S, Traczyk A, et al. MiR-135b is a direct PAX6 target and specifies human neuroectoderm by inhibiting TGF-β/BMP signaling. EMBO J. 2014;33(11):1271–83.
Google Scholar
Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005.
Google Scholar
Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL. et al. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1(3):e90
Google Scholar
Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216–21.
Google Scholar
Wang L, Chen Y, Wu S, Tang J, Chen G, Li F. miR-135a suppresses granulosa cell growth by targeting Tgfbr1 and Ccnd2 during folliculogenesis in mice. Cells. 2021;10(8):2104.
Google Scholar
Bai M, Wang P, Yang J, Zuo M, Ba Y. Identification of miR-135b as a novel regulator of TGFβ pathway in gastric cancer. J Physiol Biochem. 2020;76(4):549–60.
Google Scholar
Li J, Liang H, Bai M, Ning T, Wang C, Fan Q, et al. Correction: miR-135b promotes cancer progression by targeting transforming growth factor beta receptor II (TGFBR2) in colorectal cancer. PLoS One. 2015;10(12):e0145589.
Google Scholar
Mao XP, Zhang LS, Huang B, Zhou SY, Liao J, Chen LW, et al. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. J Transl Med. 2015;13:86.
Google Scholar
Ren JW, Li ZJ, Tu C. MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells. Int J Clin Exp Pathol. 2015;8(6):6356–66.
Google Scholar
Huang PS, Wang CS, Yeh CT, Lin KH. Roles of thyroid hormone-associated microRNAs Affecting oxidative stress in human hepatocellular carcinoma. Int J Mol Sci. 2019;20(20):5220.
Google Scholar
Calderari S, Diawara MR, Garaud A, Gauguier D. Biological roles of microRNAs in the control of insulin secretion and action. Physiol Genomics. 2017;49(1):1–10.
Google Scholar
Agarwal P, Srivastava R, Srivastava AK, Ali S, Datta M. miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle. Biochim Biophys Acta. 2013;1832(8):1294–303.
Google Scholar
Li D, An Y. MiR-135a-5p inhibits vascular smooth muscle cells proliferation and migration by inactivating FOXO1 and JAK2 signaling pathway. Pathol Res Pr. 2021;224:153091.
Google Scholar
Xu Z, Han Y, Liu J, Jiang F, Hu H, Wang Y, et al. MiR-135b-5p and MiR-499a-3p promote cell proliferation and migration in atherosclerosis by directly targeting MEF2C. Sci Rep. 2015;5:12276.
Google Scholar
Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun. 2013;4:1877.
Google Scholar
Xu S, Tang L, Li X, Fan F, Liu Z. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476:1–12.
Google Scholar
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51.
Google Scholar
Brat DJ, Aldape K, Colman H, Holland EC, Louis DN, Jenkins RB, et al. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV. Acta Neuropathol. 2018;136(5):805–10.
Google Scholar
Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, et al. Glioblastoma multiforme: the latest diagnostics and treatment techniques. Pharmacology. 2023;108(5):423–31.
Google Scholar
Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–9.
Google Scholar
Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, et al. A patient-derived glioblastoma organoid model and Biobank recapitulates inter- and intra-tumoral heterogeneity. Cell. 2020;180(1):188–204.e22.
Google Scholar
Bai J, Varghese J, Jain R. Adult glioma WHO classification update, genomics, and imaging: what the radiologists need to know. Top Magn Reson Imaging. 2020;29(2):71–82.
Google Scholar
Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell. 2017;31(6):737–754.e6.
Google Scholar
Roussel MF, Hatten ME. Cerebellum development and medulloblastoma. Curr Top Dev Biol. 2011;94:235–82.
Google Scholar
Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma. Nat Rev Dis Prim. 2019;5(1):11. Feb 14
Google Scholar
Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature. 2010;468(7327):1095–9. Dec 23
Google Scholar
Cotter JA, Hawkins C. Medulloblastoma: WHO 2021 and beyond. Pediatr Dev Pathol. 2022;25(1):23–33.
Google Scholar
Raybaud C, Ramaswamy V, Taylor MD, Laughlin S. Posterior fossa tumors in children: developmental anatomy and diagnostic imaging. Childs Nerv Syst. 2015;31(10):1661–76.
Google Scholar
Shroyer NF. Tumor organoids fill the niche. Cell Stem Cell. 2016;18(6):686–7.
Google Scholar
Tentler JJ, Tan AC, Weekes CD, Jimeno A, Leong S, Pitts TM, et al. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol. 2012;9(6):338–50.
Google Scholar
Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, et al. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol Adv. 2021;3(1):vdab100.
Google Scholar
Bian S, Repic M, Guo Z, Kavirayani A, Burkard T, Bagley JA, et al. Genetically engineered cerebral organoids model brain tumor formation. Nat Methods. 2018;15(8):631–9.
Google Scholar
Xu X, Li L, Luo L, Shu L, Si X, Chen Z, et al. Opportunities and challenges of glioma organoids. Cell Commun Signal. 2021;19(1):102.
Google Scholar
Adlakha YK, Saini N. Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. Mol Cancer. 2014;13:33.
Google Scholar
Che S, Sun T, Wang J, Jiao Y, Wang C, Meng Q, et al. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway. Tumour Biol. 2015;36(9):6805–11.
Google Scholar
Rezaei O, Honarmand K, Nateghinia S, Taheri M, Ghafouri-Fard S. miRNA signature in glioblastoma: potential biomarkers and therapeutic targets. Exp Mol Pathol. 2020;117:104550.
Google Scholar
Qiao W, Guo B, Zhou H, Xu W, Chen Y, Liang Y, et al. miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA. Biochem Biophys Res Commun. 2017;486(1):43–8.
Google Scholar
Swaroop S, Adlakha YK. Crosstalk between microRNAs and epigenetics during brain development and neurological diseases. In: Transcription and Translation in Health and Disease [Internet]. Elsevier; 2023 [cited 2024 May 11]. p. 173–207. Available from: https://linkinghub.elsevier.com/retrieve/pii/B978032399521400009X
Kwak S, Park SH, Kim SH, Sung GJ, Song JH, Jeong JH, et al. miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation. J Exp Clin Cancer Res. 2022;41(1):87.
Google Scholar
Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, et al. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med. 2009;87(1):43–51.
Google Scholar
Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 2012;31(15):1884–95.
Google Scholar
Li M, Xu H, Qi Y, Pan Z, Li B, Gao Z, et al. Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression. Oncogene. 2022;41(41):4618–32.
Google Scholar
Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S, et al. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Oncotarget. 2015;6(35):37241–56.
Google Scholar
Liang C, Sun W, He H, Zhang B, Ling C, Wang B, et al. Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma. Int J Nanomed. 2018;13:209–20.
Google Scholar
Mokgautsi N, Wen YT, Lawal B, Khedkar H, Sumitra MR, Wu ATH, et al. An integrated bioinformatics study of a novel niclosamide derivative, NSC765689, a potential GSK3β/β-catenin/STAT3/CD44 suppressor with anti-glioblastoma properties. Int J Mol Sci. 2021;22(5):2464. Feb 28
Google Scholar
Luo W, Sun C, Zhou J, Wang Q, Yu L, Bian XW, et al. miR-135a-5p functions as a glioma proliferation suppressor by targeting tumor necrosis factor receptor-associated factor 5 and predicts patients’ prognosis. Am J Pathol. 2019;189(1):162–76.
Google Scholar
Wang J, Zhang M, Lu W. Long noncoding RNA GACAT3 promotes glioma progression by sponging miR-135a. J Cell Physiol. 2019;234(7):10877–87.
Google Scholar
Istiqamah N, Matsuzaka T, Shimizu M, Motomura K, Ohno H, Hasebe S, et al. Identification of key microRNAs regulating ELOVL6 and glioblastoma tumorigenesis. BBA Adv. 2023;3:100078.
Google Scholar
Mollashahi B, Aghamaleki FS, Movafagh A. The roles of miRNAs in medulloblastoma: a systematic review. J Cancer Prev. 2019;24(2):79–90.
Google Scholar
Murphy BL, Obad S, Bihannic L, Ayrault O, Zindy F, Kauppinen S, et al. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. Cancer Res. 2013;73(23):7068–78.
Google Scholar
Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 2009;69(8):3249–55.
Google Scholar
Fiaschetti G, Abela L, Nonoguchi N, Dubuc AM, Remke M, Boro A, et al. Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. Br J Cancer. 2014;110(3):636–47.
Google Scholar
Li KKW, Pang JCsean, Ching AKkeung, Wong CK, Kong X, Wang Y, et al. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol. 2009;40(9):1234–43.
Google Scholar
Bai AHC, Milde T, Remke M, Rolli CG, Hielscher T, Cho YJ, et al. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol. 2012;123(4):529–38.
Google Scholar
Venkataraman S, Alimova I, Fan R, Harris P, Foreman N, Vibhakar R. MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence. PLoS One. 2010;5(6):e10748.
Google Scholar
Xue P, Huang S, Han X, Zhang C, Yang L, Xiao W, et al. Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2. Cell Death Differ. 2022;29(1):82–95.
Google Scholar
Zhang J, Li N, Fu J, Zhou W. Long noncoding RNA HOTAIR promotes medulloblastoma growth, migration and invasion by sponging miR-1/miR-206 and targeting YY1. Biomed Pharmacother. 2020;124:109887.
Google Scholar
Ji W, Zhe X, Li L, Cheng Y, Zhao X, Liang P, et al. Prognostic value of miR-137 in children with medulloblastoma and its regulatory effect on tumor progression. Neuromolecular Med. 2022;24(2):215–23.
Google Scholar
Miele E, Po A, Mastronuzzi A, Carai A, Besharat ZM, Pediconi N, et al. Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth. Mol Oncol. 2021;15(2):523–42.
Google Scholar
Kanchan RK, Perumal N, Atri P, Chirravuri Venkata R, Thapa I, Klinkebiel DL, et al. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain Pathol. 2020;30(4):732–45.
Google Scholar
Gokhale A, Kunder R, Goel A, Sarin R, Moiyadi A, Shenoy A, et al. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther. 2010;6(4):521–9.
Google Scholar
Choi SA, Koh EJ, Kim RN, Byun JW, Phi JH, Yang J, et al. Extracellular vesicle-associated miR-135b and -135a regulate stemness in Group 4 medulloblastoma cells by targeting angiomotin-like 2. Cancer Cell Int. 2020;20(1):558.
Google Scholar
Hemmesi K, Squadrito ML, Mestdagh P, Conti V, Cominelli M, Piras IS, et al. miR-135a inhibits cancer stem cell-driven medulloblastoma development by directly repressing Arhgef6 expression. Stem Cells. 2015;33(5):1377–89.
Google Scholar
Tantawy M, Elzayat MG, Yehia D, Taha H. Identification of microRNA signature in different pediatric brain tumors. Genet Mol Biol. 2018;41(1):27–34.
Google Scholar
Lourdusamy A, Luo LZ, Storer LC, Cohen KJ, Resar L, Grundy RG. Transcriptomic analysis in pediatric spinal ependymoma reveals distinct molecular signatures. Oncotarget. 2017;8(70):115570–81.
Google Scholar
Lourdusamy A, Rahman R, Smith S, Grundy R. microRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymoma. Acta Neuropathol Commun. 2015;3:26.
Google Scholar
Pezuk JA, Salomão KB, Baroni M, Pereira CA, Geron L, Brassesco MS. Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors. Cancer Metastasis Rev. 2019;38(4):813–28.
Google Scholar
Costa FF, Bischof JM, Vanin EF, Lulla RR, Wang M, Sredni ST, et al. Identification of microRNAs as potential prognostic markers in ependymoma. PLoS One. 2011;6(10):e25114.
Google Scholar
Cipro Š, Belhajová M, Eckschlager T, Zámečník J. MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading. Oncol Lett. 2019;17(1):1379–83.
Google Scholar
Margolin-Miller Y, Yanichkin N, Shichrur K, Toledano H, Ohali A, Tzaridis T, et al. Prognostic relevance of miR-124-3p and its target TP53INP1 in pediatric ependymoma. Genes Chromosomes Cancer. 2017;56(8):639–50.
Google Scholar
Gruszka R, Zakrzewski K, Liberski PP, Zakrzewska M. mRNA and miRNA expression analyses of the MYC/E2F/miR-17-92 network in the most common pediatric brain tumors. Int J Mol Sci. 2021;22(2):543.
Google Scholar
Liu F, Dong H, Mei Z, Huang T. Investigation of miRNA and mRNA co-expression network in ependymoma. Front Bioeng Biotechnol. 2020;8:177.
Google Scholar
Rajah Kumaran K, Yunusa S, Perimal E, Wahab H, Müller CP, Hassan Z. Insights into the pathophysiology of Alzheimer’s disease and potential therapeutic targets: a current perspective. J Alzheimers Dis. 2023;91(2):507–30.
Google Scholar
Zeliger HI Alzheimer’s disease. In: Oxidative stress [Internet]. Elsevier; 2023 [cited 2024 May 11]. pp. 291–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/B9780323918909000209
Ali B, M.S. Jamal Q, Shams S, A. Al-Wabel N, U. Siddiqui M, A. Alzohairy M, et al. In silico analysis of green tea polyphenols as inhibitors of AChE and BChE enzymes in Alzheimer’s disease treatment. CNSNDDT. 2016;15(5):624–8.
Google Scholar
Silvestro S, Bramanti P, Mazzon E. Role of miRNAs in Alzheimer’s disease and possible fields of application. Int J Mol Sci. 2019;20(16):3979.
Google Scholar
Pogue AI, Lukiw WJ. Up-regulated pro-inflammatory MicroRNAs (miRNAs) in Alzheimer’s disease (AD) and age-related macular degeneration (AMD). Cell Mol Neurobiol. 2018;38(5):1021–31.
Google Scholar
Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer’s disease. PLoS One. 2015;10(5):e0126423.
Google Scholar
Liu CG, Wang JL, Li L, Xue LX, Zhang YQ, Wang PC. MicroRNA-135a and -200b, potential biomarkers for Alzheimer׳s disease, regulate β secretase and amyloid precursor protein. Brain Res. 2014;1583:55–64.
Google Scholar
Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC. The serum exosome derived MicroRNA-135a, -193b, and -384 were potential Alzheimer’s disease biomarkers. Biomed Environ Sci. 2018;31(2):87–96.
Google Scholar
Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Wade-Martins R, Talbot K, Ben-Shlomo Y, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20(1):99–105.
Google Scholar
Wu T, Wang J, Wang C, Hallett M, Zang Y, Wu X, et al. Basal ganglia circuits changes in Parkinson’s disease patients. Neurosci Lett. 2012;524(1):55–9.
Google Scholar
Salemi M, Marchese G, Lanza G, Cosentino FII, Salluzzo MG, Schillaci FA, et al. Role and dysregulation of miRNA in patients with Parkinson’s disease. Int J Mol Sci. 2022;24(1):712.
Google Scholar
Gentile G, Morello G, La Cognata V, Guarnaccia M, Conforti FL, Cavallaro S. Dysregulated miRNAs as biomarkers and therapeutical targets in neurodegenerative diseases. J Pers Med. 2022;12(5):770.
Google Scholar
Lv K, Liu Y, Zheng Y, Dai S, Yin P, Miao H. Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson’s disease cell model. Biol Res. 2021;54(1):10.
Google Scholar
Liu Y, Liao S, Quan H, Lin Y, Li J, Yang Q. Involvement of microRNA-135a-5p in the protective effects of hydrogen sulfide against Parkinson’s disease. Cell Physiol Biochem. 2016;40(1–2):18–26.
Google Scholar
Zhang J, Liu W, Wang Y, Zhao S, Chang N. miR-135b plays a neuroprotective role by targeting GSK3β in MPP+-intoxicated SH-SY5Y cells. Dis Markers. 2017;2017:5806146.
Google Scholar
Tolosa E, Botta-Orfila T, Morató X, Calatayud C, Ferrer-Lorente R, Martí MJ, et al. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Neurobiol Aging. 2018;69:283–91.
Google Scholar
Brotman RG, Moreno-Escobar MC, Joseph J, Pawar G. Amyotrophic lateral sclerosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 May 11]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK556151/
Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197–206.
Google Scholar
Bagyinszky E, Hulme J, An SSA. Studies of genetic and proteomic risk factors of amyotrophic lateral sclerosis inspire biomarker development and gene therapy. Cells. 2023;12(15):1948.
Google Scholar
Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918–29.
Google Scholar
Freischmidt A, Müller K, Zondler L, Weydt P, Mayer B, von Arnim CAF, et al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(9):2660.e15–20.
Google Scholar
Pegoraro V, Merico A, Angelini C. Micro-RNAs in ALS muscle: differences in gender, age at onset and disease duration. J Neurol Sci. 2017;380:58–63.
Google Scholar
Ross CA, Tabrizi SJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10(1):83–98.
Google Scholar
Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C. Huntington disease: advances in the understanding of its mechanisms. Clin Park Relat Disord. 2020;3:100056.
Google Scholar
Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew SE, Zeisler J, et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet. 1994;6(4):409–14.
Google Scholar
Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park JE, et al. Altered microRNA regulation in Huntington’s disease models. Exp Neurol. 2011;227(1):172–9.
Google Scholar
Tung CW, Huang PY, Chan SC, Cheng PH, Yang SH. The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington’s disease. J Biomed Sci. 2021;28(1):59.
Google Scholar
Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, et al. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology. 2018;90(4):e264–72.
Google Scholar
Martinez B, Peplow PV. Altered microRNA expression in animal models of Huntington’s disease and potential therapeutic strategies. Neural Regen Res. 2021;16(11):2159–69.
Google Scholar
Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington’s disease. Neurobiol Dis. 2008;29(3):438–45.
Google Scholar
Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington’s disease. J Neurosci. 2008;28(53):14341–6.
Google Scholar
Hodges H, Fealko C, Soares N. Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr. 2020;9(Suppl 1):S55–65.
Google Scholar
Faras H, Al Ateeqi N, Tidmarsh L. Autism spectrum disorders. Ann Saudi Med. 2010;30(4):295–300.
Google Scholar
Garrido-Torres N, Guzmán-Torres K, García-Cerro S, Pinilla Bermúdez G, Cruz-Baquero C, Ochoa H, et al. miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2023;33(9):2957–2990
Sjaarda CP, Hecht P, McNaughton AJM, Zhou A, Hudson ML, Will MJ, et al. Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development. Sci Rep. 2017;7(1):8735.
Google Scholar
Sunwoo JS, Jeon D, Lee ST, Moon J, Yu JS, Park DK, et al. Maternal immune activation alters brain microRNA expression in mouse offspring. Ann Clin Transl Neurol. 2018;5(10):1264–76. Oct
Google Scholar
Bali KK, Kuner R. Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med. 2014;20(8):437–48. Aug
Google Scholar
Singh P, Singh M. MicroRNAs: the tiny robust players unraveling the multifaceted channels of pain. In: pain: causes, concerns and consequences [Internet]. BENTHAM SCIENCE PUBLISHERS; 2016 [cited 2024 May 11]. pp. 126–60. Available from: http://www.eurekaselect.com/node/146917
Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 2006;34(8):2294–304.
Google Scholar
Lui A, Do T, Alzayat O, Yu N, Phyu S, Santuya HJ, et al. Tumor suppressor MicroRNAs in clinical and preclinical trials for neurological disorders. Pharmaceuticals. 2024;17(4):426.
Google Scholar
Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4(9):721–6.
Google Scholar
Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203–22.
Google Scholar
Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics—challenges and potential solutions. Nat Rev Drug Discov. 2021;20(8):629–51.
Google Scholar
Laganà A, Acunzo M, Romano G, Pulvirenti A, Veneziano D, Cascione L, et al. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs. Nucleic Acids Res. 2014;42(9):5416–25.
Google Scholar
Sakai A, Suzuki H. Emerging roles of microRNAs in chronic pain. Neurochem Int. 2014;77:58–67.
Google Scholar
Wang Y, Wang Z, Shao C, Lu G, Xie M, Wang J, et al. Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109/miR-135b-3p/TOX3 axis. J Pineal Res. 2022;73(2):e12813.
Google Scholar
Yao D, Cui H, Zhou S, Guo L. Morin inhibited lung cancer cells viability, growth, and migration by suppressing miR-135b and inducing its target CCNG2. Tumour Biol. 2017;39(10):1010428317712443.
Google Scholar
Zhong M, Che L, Du M, Liu K, Wang D. Desflurane protects against liver ischemia/reperfusion injury via regulating miR-135b-5p. J Chin Med Assoc. 2021;84(1):38–45.
Google Scholar
Issler O, Haramati S, Paul ED, Maeno H, Navon I, Zwang R, et al. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron. 2014;83(2):344–60.
Google Scholar
Wang Y, Yang Z, Zhang K, Wan Y, Zhou Y, Yang Z. miR-135a-5p inhibitor protects glial cells against apoptosis via targeting SIRT1 in epilepsy. Exp Ther Med. 2021;21(5):431.
Google Scholar
Gomez-Roman N, Stevenson K, Gilmour L, Hamilton G, Chalmers AJ. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses. Neuro Oncol. 2017;19(2):229–41.
Google Scholar
Fedorova V, Pospisilova V, Vanova T, Amruz Cerna K, Abaffy P, Sedmik J, et al. Glioblastoma and cerebral organoids: development and analysis of an in vitro model for glioblastoma migration. Mol Oncol. 2023;17(4):647–63.
Google Scholar
Verduin M, Hoosemans L, Vanmechelen M, van Heumen M, Piepers JAF, Astuti G, et al. Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity. Neurooncol Adv. 2023;5(1):vdad152.
Google Scholar
Gamboa CM, Jara K, Pamarthy S, Liu L, Aiken R, Xiong Z, et al. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening. STAR Protoc. 2021;2(1):100345.
Google Scholar
Guyon J, Daubon T. Histological analysis of invasive glioblastoma organoids embedded in a 3D collagen matrix. STAR Protoc. 2023;4(3):102521.
Google Scholar
Darrigues E, Zhao EH, De Loose A, Lee MP, Borrelli MJ, Eoff RL, et al. Biobanked glioblastoma patient-derived organoids as a precision medicine model to study inhibition of invasion. Int J Mol Sci. 2021;22(19):10720.
Google Scholar
Abdullah KG, Bird CE, Buehler JD, Gattie LC, Savani MR, Sternisha AC, et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro Oncol. 2022;24(4):612–23.
Google Scholar
Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, et al. Modeling patient-derived glioblastoma with cerebral organoids. Cell Rep. 2019;26(12):3203–3211.e5.
Google Scholar
Ogawa J, Pao GM, Shokhirev MN, Verma IM. Glioblastoma model using human cerebral organoids. Cell Rep. 2018;23(4):1220–9.
Google Scholar
Krieger TG, Tirier SM, Park J, Jechow K, Eisemann T, Peterziel H, et al. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics. Neuro Oncol. 2020;22(8):1138–49.
Google Scholar
Golebiewska A, Hau AC, Oudin A, Stieber D, Yabo YA, Baus V, et al. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathol. 2020;140(6):919–49.
Google Scholar
Leite DM, Zvar Baskovic B, Civita P, Neto C, Gumbleton M, Pilkington GJ. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics. FASEB J. 2020;34(1):1710–27.
Google Scholar
Watanabe F, Hollingsworth EW, Bartley JM, Wisehart L, Desai R, Hartlaub AM, et al. Patient-derived organoids recapitulate glioma-intrinsic immune program and progenitor populations of glioblastoma. PNAS Nexus 2024;3(2):pgae051.
Google Scholar
Frisira E, Rashid F, Varma SN, Badodi S, Benjamin-Ombo VA, Michod D, et al. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma. Cell Death Dis. 2019;10(11):785.
Google Scholar
Ballabio C, Anderle M, Gianesello M, Lago C, Miele E, Cardano M, et al. Modeling medulloblastoma in vivo and with human cerebellar organoids. Nat Commun. 2020;11(1):583.
Google Scholar
Lago C, Gianesello M, Santomaso L, Leva G, Ballabio C, Anderle M, et al. Medulloblastoma and high-grade glioma organoids for drug screening, lineage tracing, co-culture and in vivo assay. Nat Protoc. 2023;18(7):2143–80.
Google Scholar
Yeh M, Wang YY, Yoo JY, Oh C, Otani Y, Kang JM, et al. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Sci Rep. 2021;11(1):9219.
Google Scholar
Liu Z, Liu Y, Li L, Xu Z, Bi B, Wang Y, et al. MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1. Tumour Biol. 2014;35(10):10177–84.
Google Scholar
Wu D-G, Wang Y-Y, Fan L-G, Luo H, Han B, Sun L-H, et al. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J. 2011;124(17):2616–21.
Google Scholar
Li Q, Wang C, Cai L, Lu J, Zhu Z, Wang C, et al. miR‑34a derived from mesenchymal stem cells stimulates senescence in glioma cells by inducing DNA damage. Mol Med Rep. 2019;19(3):1849–57.
Google Scholar
Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res. 2010;41(2):67–74.
Google Scholar
Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW, et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8. Oncogene 2011;30(7):806–21.
Google Scholar
Hong S, You JY, Paek K, Park J, Kang SJ, Han EH, et al. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment. Theranostics 2021;11(19):9687–704.
Google Scholar
Gaur AB, Holbeck SL, Colburn NH, Israel MA. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro Oncol. 2011;13(6):580–90.
Google Scholar
Yang CH, Yue J, Pfeffer SR, Fan M, Paulus E, Hosni-Ahmed A, et al. MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). J Biol Chem. 2014;289(36):25079–87.
Google Scholar
Kwak HJ, Kim YJ, Chun KR, Woo YM, Park SJ, Jeong JA, et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011;30(21):2433–42.
Google Scholar
Schramedei K, Mörbt N, Pfeifer G, Läuter J, Rosolowski M, Tomm JM, et al. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 2011;30(26):2975–85.
Google Scholar
Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369–80.
Google Scholar
Gabriely G, Yi M, Narayan RS, Niers JM, Wurdinger T, Imitola J, et al. Human glioma growth is controlled by microRNA-10b. Cancer Res. 2011;71(10):3563–72.
Google Scholar
Guessous F, Alvarado-Velez M, Marcinkiewicz L, Zhang Y, Kim J, Heister S, et al. Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol. 2013;112(2):153–63.
Google Scholar
Dews M, Fox JL, Hultine S, Sundaram P, Wang W, Liu YY, et al. The myc-miR-17–92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. Cancer Res. 2010;70(20):8233–46.
Google Scholar
Shu C, Wang Q, Yan X, Wang J. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma. Clin Transl Oncol. 2018;20(11):1439–47.
Google Scholar
Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, et al. MicroRNAs in Alzheimer’s disease: potential diagnostic markers and therapeutic targets. Biomed Pharmacother. 2022;148:112681.
Google Scholar
Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL. MicroRNA dysregulation in parkinson’s disease: a narrative review. Front Neurosci. 2021;15:660379.
Google Scholar
Cheng PH, Li CL, Chang YF, Tsai SJ, Lai YY, Chan AWS, et al. miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models. Am J Hum Genet. 2013;93(2):306–12.
Google Scholar
Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58(2):261–9.
Google Scholar
Russell AP, Wada S, Vergani L, Hock MB, Lamon S, Léger B, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis. 2013;49:107–17.
Google Scholar
De Felice B, Guida M, Guida M, Coppola C, De Mieri G, Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 2012;508(1):35–40.
Google Scholar
Vrabec K, Boštjančič E, Koritnik B, Leonardis L, Dolenc Grošelj L, Zidar J, et al. Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic ALS patients. Front Mol Neurosci. 2018;11:106.
Google Scholar
Urdinguio RG, Fernandez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010;5(7):656–63.
Google Scholar
link
